Check out our most popular compounded medications! Get Started
Dashboard
Formulas

2-Deoxy-D-Glucose 0.2% Oral Rinse

FDA-approved generic
Dose form
Oral Rinse
Active ingredients
2-Deoxy-D-Glucose
For prescribers
Prescription details
RxThis formula
Dose formSee below
Quantity____
SigAs directed by prescriber
Refills____
PharmacyBayview Pharmacy, Warwick RI, NCPDP 4106882
Copy prescription detailsOrder form
Controlled substance: e-prescribe (EPCS) from your EHR. Faxed and phoned prescriptions cannot be accepted for this preparation.
Send it from your EHR, or fax to (401) 284-4506. How to e-prescribe this formula
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
To prescribe, you must be a verified prescriber.
To prescribe, you must be in a state where we hold an active out-of-state pharmacy license.
Starting at
Fill my prescription
Fill my prescription
Requires a prescription from your own provider. Bayview is a pharmacy and does not prescribe.
Save 15% on every refill when you enroll in Automatic Refills
Ships within 1 to 2 business days after pharmacist verification
HSA and FSA eligible
Check if we ship to your state
No prescription yet?

Get a sheet with everything your doctor needs to prescribe this and send it to Bayview.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.

For prescribersSign in for prescription details and order forms.
Compounded preparations are prepared by Bayview pursuant to a prescription for an individual patient. They are not FDA-approved and have not been evaluated by FDA for safety or effectiveness.
2-Deoxy-D-Glucose
Oral Rinse
652eedfb80612a4143818b82
Service area

Can we ship this formula to your state?

Bayview fills prescriptions for patients in Connecticut, Florida, Maine, Massachusetts, New Hampshire, New Jersey, Pennsylvania and Rhode Island. New York patients are served on a limited basis while nonresident pharmacy registration is pending.

Check your state

Available in

Tap a state to check it.

Our current service area

Currently licensed Limited basis, registration pending Not available for this formula Not currently licensed

Select a state on the map or use the checker.

Prepared to a prescriber's order for one patient. Not FDA-approved.

This formulation

This is a compounded oral rinse containing 2-deoxy-D-glucose, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.

FDA product listings

These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.

No product listing under the name 2-deoxy-D-glucose was found in the directory.

Storage category and dating

This dose form is water-containing (aqueous). Under USP <795>, aqueous preparations carry shorter default beyond-use dates than nonaqueous ones, and a preservative in the base allows a longer date than no preservative. The date printed on the label is the one to follow.

Sources

Why prescribers order this

Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.

2-Deoxy-D-glucose is an investigational glucose analog that blocks glycolysis; no FDA-approved drug product contains it, and it is compounded only by prescription.

About this ingredient

2-Deoxy-D-glucose (2-DG) is a naturally occurring glucose analog in which one hydroxyl group is replaced by hydrogen. Cells take it up like glucose, but it cannot be fully metabolized, so it competitively inhibits glycolysis and also interferes with N-glycosylation of proteins. There is no FDA-approved drug product containing 2-DG, and a DailyMed label search returns no products for it. Its radiolabeled relative, fludeoxyglucose F 18 injection, is an FDA-approved imaging agent used for PET scans in cancer, heart and epilepsy evaluation; that is a different product. FDA lists "Deoxy-D-Glucose" among bulk substances nominated for 503A compounding that remain under evaluation (Category 1). Compounded preparations are not FDA-approved and require a prescription.

Safety and interactions

Because 2-DG has no FDA label, there is no labeled boxed warning, contraindication list or interaction table. A 2023 peer-reviewed review reports that, at doses above those found tolerable in people, side effects included reversible high blood sugar, gastrointestinal bleeding and QTc prolongation, a change in heart rhythm seen on an ECG, and states that the safest doses, toxicity and interactions of 2-DG still need investigation. Tell your prescriber about any heart rhythm problem, diabetes, stomach or bowel bleeding, and every medicine and supplement you take. No pregnancy or breastfeeding data were found in the sources reviewed, so discuss pregnancy or nursing with your prescriber before use. For black stools, fainting, a racing or irregular heartbeat, or other side effects, talk to your prescriber or pharmacist.

2-DG is a nonmetabolizable glucose analog and a competitive inhibitor of glycolysis. Per the Singh 2023 review, its toxic effects stem mainly from blocking glycosylation rather than glycolysis, and a ketogenic diet increased tolerance to glycolysis inhibitors in reported work. It has been studied as an anticancer agent and radiosensitizer, as an antiviral, as an anti-inflammatory, and for antiseizure effects and slowing of epilepsy progression in animal models. The Drugs Controller General of India granted emergency use approval for 2-DG in COVID-19 on May 1, 2021; it has no FDA approval for any indication. Reported adverse effects above the tolerable dose range include reversible hyperglycemia, gastrointestinal bleeding and QTc prolongation, and the review calls for further work on dosing, mechanism, toxicity and interactions. There is no labeled indication; any use is off-label and investigational, and dosing is per prescriber. Monitoring considerations that follow from the reported adverse effects include blood glucose, ECG with QTc, and signs of gastrointestinal bleeding. FDA lists "Deoxy-D-Glucose" in Category 1 of its 503A nominations (updated May 14, 2026), meaning it is under evaluation and FDA does not intend to act against 503A compounders using it if conditions are met. 2-DG is not a controlled substance.

Sources

Using and storing

How it is used

Measure the amount shown on your label with the cup or syringe provided. Swish it around your mouth for the time on your label, often 30 seconds or longer, then spit it out unless your label says to swallow. Do not eat, drink or rinse with water for a while afterward as directed. Shake the bottle first if your label says to.

Storing it

Oral rinses are aqueous. Under USP <795>, a preserved rinse usually carries a beyond-use date of up to 35 days at room temperature or refrigerated, and an unpreserved one 14 days refrigerated. Your label states whether to refrigerate and the beyond-use date. Keep out of reach of children and discard after that date.

Sources

Prescribing and ordering FAQs

Formula Information

A small arrow pointing down

Drug Interactions

A small arrow pointing down

How Does it Work

A small arrow pointing down

Frequently Asked Questions

A small arrow pointing down

About this compounded preparation

This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.

A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.

This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.

Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.

No compounded medications are reviewed by the FDA for safety or efficacy.
For prescribers

How to e-prescribe this formula

Controlled substance: e-prescribe only (EPCS). Faxed, phoned, and handwritten prescriptions cannot be filled. Rhode Island law (R.I. Gen. Laws § 21-28-3.18) requires Schedule II to V prescriptions to be transmitted electronically.
1

Find Bayview in your EHR's pharmacy directory

Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.

NCPDP4106882NPI1750455143Address3844 Post Rd, Warwick, RI 02886Phone(401) 284-4505Fax(401) 284-4506
2

Enter the formula as a compound

Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.

Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.

3

Copy the prescription details

RxFormula name
Dose formDose form
Quantity________
SigAs directed by prescriber
Refills____
PharmacyBayview Pharmacy, Warwick RI, NCPDP 4106882
Copy prescription details

Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.

4

Send it

Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.

Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.

Do not use Notes to Pharmacy for the formula. Some EHRs keep that field internal and never transmit it. A prescription that arrives without the formula is delayed while we call your office.

Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.

2-Deoxy-D-Glucose 0.2% Oral Rinse
Oral Rinse
450 mL
controlled

Rinse mouth

Four times daily